Awarded
Ipilimumab
Original language: Polish
Track this recordWith Adjudera Pro, get alerted before a contract here runs out.
- Winners
- Roche Polska Sp. z o.o. z
- Contract value
- PLN 166,535
- Bids received
- 1
- Published
- 26 Oct 2026
- Awarded
- 14 Aug 2025
- Contract start
- 14 Aug 2025
- Contract end
- 27 Aug 2026estimated
- Region
- Warszawski wschodni
More awards from this buyer
| Awarded | Buyer | Winner | Contract value | Published |
|---|---|---|---|---|
| Entrektynib | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Urtica Sp. z o.o. | PLN 617,322 | 26 Oct 2026 |
| Tremelimumab | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Astra Zeneca Kft | PLN 1,512,081 | 26 Oct 2026 |
| Cemiplimab | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Urtica Sp. z o.o. | PLN 97,603 | 26 Oct 2026 |
| Vincristina | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | SALUS INTERNATIONAL Sp. z o.o. | PLN 300 | 26 Oct 2026 |
| Durvalumab | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Astra Zeneca Kft | PLN 1,734,443 | 26 Oct 2026 |
| Osimertynib | Mazowieckie Centrum Leczenia Chorób Płuc i Gruźlicy | Astra Zeneca Kft | PLN 2,123,551 | 26 Oct 2026 |